konectar

Identifying Digital Opinion Leaders in the ever-evolving digital landscape is no easy task. The dynamic nature of influencers and the availability of limited surface-level metrics add to the complexity.

The future of drug development in the pharmaceutical industry is poised for exciting advancements. We'll see:

Precision Medicine: Advances in genomics and molecular biology will enable pharmaceutical companies to develop treatments depending on an individual's genetic makeup. This means therapies can be more effective and have fewer side effects since they're designed to address the specific causes of diseases in each patient.

AI and Big Data: Artificial intelligence and big data analytics will become integral to drug discovery. Machine learning algorithms can analyze vast datasets to identify potential drug candidates, predict their safety and efficacy, and even simulate clinical trials. This significantly speeds up the research and development process, potentially reducing costs and time to market.

Biotechnology: Advances in biotechnology are opening up new possibilities for treating complex diseases like cancer, genetic disorders, and autoimmune conditions.

Biologics, which are drugs derived from living organisms, are a growing focus in the pharmaceutical industry. These include monoclonal antibodies, gene therapies, and cell-based therapies. 

Patient-Centric Focus: Patients will become increasingly active participants in their healthcare decisions. Digital Health Analytics solutions, telemedicine, and wearables are empowering patients to manage their conditions and collect valuable data that can inform drug development.

Regulatory Innovations: Regulatory agencies are adapting to the changing landscape of drug development. They are implementing faster approval pathways to expedite access to promising treatments for serious conditions. Additionally, regulatory agencies are exploring ways to incorporate real-world evidence into decision-making.

Digitalization is changing the healthcare space, and the COVID-19 pandemic has been responsible for it in some ways. As innovation in biosciences and technology is advancing rapidly, top life sciences companies are gearing up to discover and launch new drugs or products. When any new drug or a product is discovered and goes through its product life cycle, life sciences companies require the guidance of key opinion leaders and digital opinion leaders to take the product from discovery to commercialization.

According to a 2019 PubMed survey conducted on social media usage by plastic surgeons, it was found that “62% of plastic surgeons have active professional social media accounts.” On Twitter, “tweets with “#PedsICU” were shared 49,865 times on six continents between February 1, 2020, and May 1, 2020.”

Is there a way the life sciences industry can utilize the influence of digital opinion leaders for their drug or product? Read on to learn more about the benefits life sciences companies can reap from digital opinion leaders' expertise.

Who Are DOLs?

Digital Opinion leaders (DOLs) are the new breed of HCPs that have arisen recently. DOLs are healthcare professionals (HCPs) who use digital platforms like social media to disseminate medical and scientific information to their patients, peers, and followers.  DOLs do not frequently attend conferences or do not publish articles in journals, but their goal is to share valuable and engaging content to educate their community. DOLs are not social media influencers but are the real “thought leaders” as they do not self-promote themselves but are advocates of the brand they promote.

Specific to healthcare, the top influencers (DOLs) can be HCPs and non-HCPs. They range from physicians, allied health professionals, medical & scientific writers, caregivers, nurses, and pharmacists to patient advocates, industry analysts, cancer survivors, health bloggers, journalists, and patients. The non-HCPs Digital opinion leaders use the social media platform to write about general topics in healthcare like innovations in the healthcare landscape, and trending topics on specific diseases like cancer, diabetes, etc. Non-HCP DOLs also disseminate information in their groups but the information is mostly generic and may or may not be scientific.

Why Should Life Sciences Companies Engage DOLs?

Kol Pharma and management in life sciences organizations have been the “bread and butter strategy” for decades. A traditional KOL can be influential in terms of the conference attended or articles written, but it is the DOL who can increase the reach of this medical and scientific content through social media.

Leveraging the influence, the Digital Opinion Leaders in Healthcare have on digital platforms, life sciences companies can utilize their DOLs:

In amplifying the brand messaging the company wants to propagate.

Helping the life sciences companies recruit new talent with their influence on digital platforms (clinical trial recruitment).

By collaborating on developing marketing materials and providing valuable feedback.

Assisting the medical and marketing team in creating educational material for patients.

Acting as spokesperson/member of the advisory board/judges for contests, etc.

By sharing their voices on disease awareness, best practices, and the new initiatives, the life science company is undertaking.

By involving DOLs and building meaningful relations with them over a while, life sciences companies can reach potential customers they hadn't even noticed before with just a click of a button.

How Can Life Sciences Companies Identify and Engage DOLs?

“The 5 Ws” must be answered by the Life sciences companies before identifying and engaging DOLs.

Why Should Life Sciences Companies Identify DOLs?

The medical and commercial teams should be clear on the strategy and objective of the brand to be advocated before deciding on the DOLs.

When Should Life Sciences Company Think About Identifying DOLs?

The life science company should know the challenges or opportunities they are trying to resolve by identifying DOLs.

 What Parameters Should be Considered to Identify The Right DOLs?

●      Are they posting relevant and innovative content online?

●      Do these DOLs have a solid digital presence (public and peer following?)

●      Do their peers believe their voice and content? (Are they trustworthy?)

●      Are they influential offline too?

●      Are they already engaged with your company on different projects?

 Who is the right DOL to Engage?

After addressing the WHAT, let’s talk about the WHO.  

●      Who is the DOL (HCP) sharing content relevant to the company's therapeutic area/ brand?

●      What is the specialty and sub speciality of the concerned DOL?

●      How is the quality of the content that the DOL shares?

●      How frequently does the DOL post the content?

●      Is this DOL engaging with its peers, or is it a one-way communication by just posting the content online?

How to engage DOLs?

Once the DOLs have been identified and mapped, a team member (medical/commercial) must communicate with them. Face-to-face meetings are preferred mainly by DOLs so that they can meet the teams in person and understand their engagement objective.

 As the healthcare landscape is rapidly driven by technological advancement, It is essential that life sciences companies use advanced software tools to identify, map and engage Digital Opinion Leaders.

konectar Social- our robust digital opinion leader platform is built on the latest technology combined with an NLP framework for accurate web crawling and entity extraction. konectar Social has several features which enable Life Sciences companies to find the right Digital Opinion Leader from drug discovery to commercialization.

 How Can Life Sciences Companies Utilise the Expertise of DOLs?

Life sciences companies should customize DOL engagement strategy according to their business goals. Here are a few common ways life sciences companies can engage DOLs and utilize their skills efficiently:

a.    Empower the DOLs with knowledge and resources

Life sciences companies must educate and train their DOLs on the drug/ product that the DOLs will be advocates for. The internal team should share the resources prepared for that therapeutic area with the digital thought leaders. These resources would help the DOLs disseminate their platform's correct information to their audience.

b.    Understand their areas of interest

This is imperative when the Medical Science Liaisons’ (MSLs) interact with the DOLs. The MSLs should be aware of the DOLs area of expertise so that relevant topics are discussed with them.

c.    Form an advisory board of DOLs

As with KOLs, life sciences companies should form similar advisory boards with the top DOLs to obtain more diverse insights. As the DOLs interact with communities, patients, and peers online, they can bring a fresh and unique perspective regarding new research, the latest launches, drugs, or products concerning their therapeutic area. This can help life sciences companies to innovate and explore new avenues.

d.    Help the DOLs to increase their reach

Some DOLs may be active on one or two digital platforms. Life sciences companies can assist and guide the DOLs to use other platforms according to their therapeutic needs. This collaboration will benefit the life sciences companies in promoting their drug or product on multiple platforms and will aid the DOLs in increasing their community network.

e.    Build and strengthen relationships with DOLs

Life sciences companies must deepen their relationship with their DOLs by empowering them with company insights, resources, events, etc., so they can better understand the digital space.

f.      Engage on Digital Platforms with DOLs

Medical & commercial teams should chat, organize webinars, tweet, etc., with the DOLs to build long-lasting relationships by sharing medical and scientific insights. This will empower the DOLs to reach out to the relevant communities online.

g.    Keep track of the competitor DOLs.

It is always essential to keep track of the competition. Life sciences companies should track the activities that the competitor DOLs are into. This will help them strategize better.

The future of Digital Opinion Leaders' engagement in the Life Sciences Industry

The evolving healthcare landscape has bought about a change in the work perspective of life sciences companies. The DOLs have become indispensable to organizations and are here to stay!

●      Life sciences companies have become digitally active and are enhancing their presence on digital platforms by engaging DOLs. To transform and grow, life sciences companies in the future would need to co-work with both KOLs and DOLs on the same platform for generating insights, creating materials, and disseminating knowledge rather than working with either one. This will enhance the strength and reach of the life sciences companies.

●      A new breed of thought leaders apart from KOLs and DOLs are paving their way into the life sciences space- they are known as Digital Scientific Leaders (DSLs). DSLs are DOLs with excellent scientific knowledge and credentials; they use digital platforms to disseminate information about the latest clinical studies, trials, diagnoses, and treatment mechanisms. In the future that we look upon, life sciences companies will be hiring KOLs, DOLs, and DSLs together for broader and deeper reach.

In the healthcare space key opinion leader software contribute at every stage of the drug/device development life cycle, from discovery to marketing and end-user outreach.

To support KOL engagement, begin with the aid of identifying influential individuals in specific regions and within appropriate geography. Identify who is continually talking at essential clinical meetings and medical conferences, and who is publishing scientific articles or is regularly quoted in the media for his or her medical knowledge.

Next, take into account what your KOLs need: How critical is it for them to travel for work and their preferences to travel to a meeting? Are they comfortable discussing in face-to-face meetings? Are they emerging experts who are probably reluctant to speak up around experienced clinicians?

While it’s actual that any professional chief can thrive in a digital setting, your clinical KOL control members may discover it useful to understand which individuals are surely extra comfortable and authoritative. Allowing the KOLs to use the location in which they’re more convenient to participate in a significant manner is a win-win situation. Wherein your team collects a greater number of medical insights and the KOL can share their knowledge while persevering to set up their vicinity along with different specialists inside the pharmaceutical industry.

Influence of KOLs in the medical space

Trustworthiness, credibility, and authority are all essential qualities in KOLs. However, in a digital placing, your teams may even want to identify professionals who are proactive, have a partnership mindset, and share a hobby in collaborative expertise change. Building an in-depth skill is crucial for research findings ahead.

KOL’s prominence is the most important phenomenon. Life Sciences companies also gain from their learning with newer KOLs who may not be part of their radar. These KOLs are probably micro-influencers in their specific field or specialty, and they may bring to the table deeper information of subjects that can be essential for Life Sciences teams to apprehend.

With the rise of digital settings, most clients discover that demography, not being tech-savvy do not prevent the KOLs from participating in virtual meetings or discussions.

In-depth Profiling of KOLs

KOL profiling is crucial for the Life Sciences team to understand the key opinion leaders in-depth and see who are the right experts to be engaged for their different KOL initiatives. This is a quantitative method to figure out KOLs on a local, national, and international stage – know-how pharma teams can use in getting absolute precise results for unique obligations and research.

By identifying individuals with expertise in unique regions and profiling, they are in line with their level of lifestyles, technological know-how teams can easily verify who to have interaction for enormously targeted remarks on loads of subjects. The goal is to have different tiers of KOLs and to boost up commercialization or product adoption in the Life Sciences space. Identifying a KOL for research to help acquire fulfillment in a scientific field is imperative.

In an ideal situation, it can seem much less crucial to get into the in-depth data since there is no capping on how many Key Opinion leaders Life Sciences companies want to engage for their initiatives. However, concerning KOL control in pharma, it’s still critical to perceive the professionals who can provide the maximum relevant and actionable perception in your medical team.

Engaging the KOLs virtually

Identifying the proper KOLs is important no matter how hard it is. But bear in mind that a digital approach can offer what many professionals need from knowledge-sharing possibilities: comfort, exposure to international perspectives, time for notion and reflection, and more common opportunities for studying and interaction. A digital engagement is a superb low-impact strategy to nurture up KOL relationships all year length.

Role of kol medical and brand influencers for successful brand promotion

While influencers – which includes folks that represent customer manufacturers – are especially encouraged by self-merchandising, KOLs are moved to promote technological know-how and information or increase the profile in their profession, research, or patient management. They have deep information about their therapeutic location and recognize the effect of sharing that information with existing technology groups.

Who are Kol Pharma ? As Healthcare Professionals are seeking to choose from a wide range of remedy options for his or her patients, they regularly are looking for assist from fellow physicians for expertise and recommendation about precise capsules or treatment alternatives. Key opinion leaders have a good popularity because their validity is usually primarily based on years of experience and know-how in the subject. As a result, Life sciences agencies have began to rely on key opinion leaders to assist them construct a know-how base on their pills/gadgets and enlarge their markets into different disciplines and geography.

KOLs are an extremely valuable and fundamental issue for Life Sciences groups. The principal goal of getting a KOL Management machine is to inspire and keep ongoing relationships and build an excellent network of Thought Leaders.

What is KOL Management?

Given a massive wide variety of capability KOLs Life Sciences groups engage, the agency-huge adoption of HCPs courting management is an vital part of any KOL initiative software. KOLs are engaged throughout more than one departments inclusive of Medical Affairs, Clinical Affairs, Scientific Affairs, Marketing, and Commercial groups, but there may be a shortfall of monitoring the relationship with KOLs and overlaps of a couple of teams drawing near the equal Pharma KOL for one of a kind initiatives. Mismanagement of the KOL relationships can fee Life sciences organizations thousands and thousands of greenbacks spent at the side of compliance issues or troubles.

Although specific KOL control practices vary relying on the size of the corporation, the kind, and the commitment in the market, they frequently comprise the same critical elements. To engage Kol Pharma efficiently, it will become vital to have a strategic plan to become aware of and map the proper Opinion Leaders primarily based on the business goals. Every KOL control software ought to be bendy to the changes in era, events, plans and desires, and market changes. Mostly, it’s become a important thing for Life Sciences organization to broaden transparency for retaining collaboration with KOLs.

What is the significance of Kol Pharmaceutical ?

The emergence of KOL management in Life sciences corporations has surely shifted cutting-edge technology to a developing trend of edition and personalization. To correctly manipulate KOL relationships, Life sciences agencies need a robust answer that meets the wishes of each Key Opinion Leader and the elements of the important thing courting. The circulate closer to variation and personalization is the reason why groups also are evaluating applications to installation strong KOL Management systems.

To efficaciously enhance relationships with KOLs, Life Sciences groups ought to first discover the way each KOL wants to be engaged after which layout a approach based totally on these person necessities and expectations. As a part of the overall KOL Management approach, the Platforms must be capable of adapt to the changes in the market and rearrange their answer to meet the targets of the businesses.

What is the Influence of Kol Pharmaceutical?

In latest months, it's been feasible for Life Sciences companies to control and music the effects performed by their comprehensive KOL management projects. However, the consequences of these programs are often intangible and hard to measure and ensure there is transparency in guide of the compliance with the brand new country and federal pointers. In recent instances, Life Sciences agencies have began to undertake strategic KOL mapping answers that permit the reaching the communique goals, together with each the well timed reporting of key metrics and alignment with compliance guidelines.

Understanding the Healthcare Professionals’ community, their professional activities, Clinical pursuits and their engagement with Life Sciences businesses are important to maximizing the effectiveness of KOLs. With established tactics, strategy and technologies, it's far possible to music the impact of the KOL software for specific engagements. Experienced marketers from the Life Sciences industry will agree that a success KOL management answers want to be mapped with advertising, commercial enterprise, and compliance desires as the connection with Key Opinion Leaders broaden.

The prominence of KOL Management within the future